SILO: Silo Pharma Company Value to Net Income

Symbol and logo of brand Silo Pharma Inc. (SILO)

Silo Pharma, Inc. (SILO) has earned physician recognition by synthesizing neurology and psychedelics while maintaining high shareholder loyalty. However, the company faces pressure from biotech behemoths in the race for patents. This chart shows the market price is fixed at -0.90. The business relies on IT platforms that automate the selection of drug formulas, relieving scientists of monotonous routine.

SILO (Silo Pharma, Inc.) Price to Earnings Ratio history from 04/28/2023 to 11/15/2026

Comprehensive metric breakdowns and analytics for Silo Pharma Inc. (SILO)

- price and consensus price forecast:
Stock Price Silo Pharma|SILO - Consensus Target
- market capitalization information:
Market Value Silo Pharma|SILO - Total Company Value
- balance sheet net asset value indicators:
Share Book Value Silo Pharma|SILO - Company Book Value|Market Capitalization to Book Value silopharma.com|SILO - Cumulative Company Assets
- company liabilities and liquidity data:
Debt to Capital Silo Pharma, Inc.|SILO - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Silo Pharma|SILO - Company Aggregate Debts|Debt to Net Assets Ratio Silo Pharma|SILO - Company Long-Term Debt|Short-Term Debt Silo Pharma|Interim Coverage Ratio silopharma.com
- net income and valuation multiples indicators:
SILO - Net Profit|Company Profit Forecast Silo Pharma, Inc.|SILO - Price to Earnings Ratio|Future Price to Earnings silopharma.com|SILO - Price/Earnings to Growth Ratio|Company Value to EBITDA Silo Pharma, Inc.|SILO - Operating profit before deduction of amortization|Earnings per share for the trailing year Silo Pharma|SILO - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months silopharma.com|SILO - Earnings growth in current year|Expected earnings per share trend next year Silo Pharma, Inc.
- sales volume and revenue indicators:
SILO - Revenue and Sales Volume|Projected Sales Volume Silo Pharma Inc.|SILO - Price-to-Revenue Ratio|Forward Price to Sales Silo Pharma|SILO - Sales Growth YoY (Last Twelve Months)
Summary company analysis:silopharma.com - SILO
Original product of Silo Pharma

The P/E ratio serves as a key filter when stress-testing assets and determining whether a security is overbought. This metric measures the investment payback period by comparing market capitalization to the business's net income. By analyzing the monthly P/E dynamics of a company, an investor can see the current value of -0.90. For Silo Pharma, Inc. (SILO), this indicator reflects market expectations regarding the success of microdosing in treating neurological pathologies. High values here signal that the market is betting on future innovative breakthroughs by management.

Analysis of competing companies

P/E Multiple Alkermes Inc.|Price to Earnings Ratio AVDL (Avadel Pharma)|ATAI (atai) - Company Value to Net Income|Price to Earnings Ratio GH Research Corp GHRS|MNMD (mindmed.co) - Market Cap to Net Income|CMPS - Price to Earnings Ratio|Business Payback Period LB Pharma LBRX|DRUG (brightmindsbio.com) - Price to Earnings Ratio|Market Cap to Earnings Vanda Pharmaceuticals Inc (VNDA)|CYBN (cybin.com) - P/E Multiple|Price to Earnings Ratio Alto Neuroscience, Inc. (ANRO)|P/E Multiple NRXP|CING (Cingulate Inc) - Company Value to Net Income|Price to Earnings Ratio China Pharma Holdings, Inc. CPHI|Clearmind Medicine (CMND) - Market Cap to Earnings|PBM - Price to Earnings Ratio|Business Payback Period SciSparc Ltd SPRC|SEEL: P/E Multiple|VRPX - Business Payback Period|Price to Earnings Ratio Karuna